Deals
Temasek Prepares $1 Billion Zuellig Pharma Stake Sale
- Singapore state fund prepares potential sale of 20% holding
- Zuellig owns vast distribution networks in a dozen countries
This article is for subscribers only.
Temasek Holdings Pte is exploring a sale of its stake in Asian drug distributor Zuellig Pharma, people familiar with the matter said.
The Singapore state investment firm has been speaking with advisers about a potential sale of its 20 percent interest in Zuellig Pharma, which commands vast pharmaceutical distribution networks in about a dozen Asian markets, according to the people. Temasek may seek around $1 billion for its holding in the Singapore-based company, the people said, asking not to be identified because the discussions are private.